PELAIA, GIROLAMO
 Distribuzione geografica
Continente #
NA - Nord America 3.169
AS - Asia 1.388
EU - Europa 1.274
SA - Sud America 135
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 5.990
Nazione #
US - Stati Uniti d'America 3.053
SG - Singapore 1.010
IT - Italia 649
CN - Cina 251
DE - Germania 156
SE - Svezia 138
GB - Regno Unito 132
BR - Brasile 113
CA - Canada 101
FI - Finlandia 59
IN - India 27
NL - Olanda 23
HK - Hong Kong 22
ES - Italia 19
FR - Francia 17
RU - Federazione Russa 15
CZ - Repubblica Ceca 13
BD - Bangladesh 12
MX - Messico 9
TR - Turchia 9
IE - Irlanda 8
JP - Giappone 8
PL - Polonia 8
VN - Vietnam 8
PE - Perù 7
RO - Romania 7
AU - Australia 6
UA - Ucraina 6
EU - Europa 5
ID - Indonesia 5
IL - Israele 5
PK - Pakistan 5
TW - Taiwan 5
AT - Austria 4
CL - Cile 4
IR - Iran 4
TT - Trinidad e Tobago 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
DK - Danimarca 3
EG - Egitto 3
LT - Lituania 3
PT - Portogallo 3
AR - Argentina 2
CO - Colombia 2
EC - Ecuador 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 5.990
Città #
Chandler 574
Singapore 430
Santa Clara 294
Milan 241
Lawrence 227
Princeton 227
Wilmington 144
London 109
Chicago 108
Munich 94
Ottawa 91
Ashburn 77
Des Moines 71
Catanzaro 67
Turku 44
Shanghai 30
Boardman 27
Rome 22
Naples 21
Hong Kong 20
Guangzhou 19
Redwood City 19
Norwalk 18
The Dalles 18
Beijing 16
Hanover 16
Los Angeles 16
Palermo 16
San Francisco 16
San Nicola Manfredi 16
Seattle 16
Redmond 15
Troina 15
New York 14
São Paulo 14
Brooklyn 13
Olomouc 13
Columbus 12
Helsinki 12
Atlanta 10
Phoenix 10
Florence 9
Pune 9
Shenzhen 9
Boston 8
Warsaw 8
Ankara 7
Augusta 7
Dublin 7
Falls Church 7
Mexico City 7
Rogliano 7
Wuhan 7
Assago 6
Bologna 6
Council Bluffs 6
Ferrara 6
Lima 6
Mountain View 6
Padova 6
Paris 6
Salerno 6
Wuxi 6
Jiaxing 5
Quanzhou 5
Shenyang 5
Turin 5
Amsterdam 4
Ann Arbor 4
Aversa 4
Cherasco 4
Crotone 4
Dallas 4
Hanoi 4
Horia 4
Lamezia Terme 4
Providence 4
Rende 4
Rui'an 4
San Mateo 4
Taipei 4
Tokyo 4
Xi'an 4
Afragola 3
Aiello Calabro 3
Belo Horizonte 3
Brookline 3
Buffalo 3
Campinas 3
Charlotte 3
Curitiba 3
Dhaka 3
Genoa 3
Houston 3
Jinan 3
Kemerovo 3
Miami 3
Muggiò 3
Nashville 3
Raleigh 3
Totale 3.519
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 77
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 67
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 63
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 63
Application of proteomics and peptidomics to COPD 54
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 54
High-flow nasal oxygen therapy in intensive care and anaesthesia 50
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 50
Asthma and COPD proteomics: Current approaches and future directions 49
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 49
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 47
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 45
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 44
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 43
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 41
A case of alveolar proteinosis associated with pulmonary nocardiosis 41
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 41
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 40
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 40
Alpha-interferon and its effects on signal transduction pathways 39
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 39
The severe asthma network in Italy: findings and perspectives 38
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 38
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 38
Airways smooth muscle response to biological stimuli 37
Adverse drug reactions in hospitalized patients following NSAIDs administration 37
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 36
Adverse drug reactions in hospitalized patients following antibiotics administration 36
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 36
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 36
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 35
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 35
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 35
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 35
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 35
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 35
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 35
Agonisti beta2-adrenergici 34
Enfisema polmonare 34
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 34
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 34
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 34
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 33
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 33
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 33
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 33
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 33
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 33
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 33
Dupilumab: a novel treatment for asthma 32
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 32
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 32
Anticolinergici 32
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 32
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 32
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 32
Bronchial asthma induced by an antithyroid drug 31
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 31
I beta2-adrenergici 31
Oxidative Stress and Respiratory Disease 31
Adverse drug reactions in hospitalized patients following bronchodilators administration 31
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 31
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 31
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 31
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 31
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 31
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 31
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 30
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 30
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 30
null 30
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 29
VIP: a new promising marker for AECOPD or a fashionable marker soon forgotten? 29
Role of biologics in severe eosinophilic asthma - focus on reslizumab 29
Omalizumab riduce la frequenza delle riacutizzazioni, l’assunzione orale di corticosteroidi e l’eosinofilia ematica in pazienti atopici con asma cronico severo 29
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 29
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 29
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 29
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 28
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 28
Exhaled nitric oxide during humming: potential clinical tool in sinonasal disease? 28
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 28
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma 28
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 28
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 28
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 28
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 27
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review 27
New perspectives in asthma treatment 26
Targeted therapy in severe asthma today: focus on immunoglobulin E 26
Respiratory infections and asthma 26
Basi biomolecolari delle pneumopatie interstiziali: Azione degli steroidi sul rilascio delle citochine 26
Nitric oxide in upper airways inflammatory diseases 25
The potential of biologics for the treatment of asthma 25
STRUCTURE OF THE RAT GENE ENCODING THE MITOCHONDRIAL BENZODIAZEPINE RECEPTOR 25
Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics 25
Antimuscarinici 25
Azioni degli steroidi sul rilascio delle citochine 25
Effect of TGF-beta and budesonide an MAPK activatin and apoptosis in airway epithelial cells 25
Adverse drug reaction in two pneumology units of Catanzaro 25
Totale 3.484
Categoria #
all - tutte 96.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 27 2 7 33 24 13 7 6 86 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.733 412 137 97 105 196 345 93 75 351 145 284 493
2025/202676 76 0 0 0 0 0 0 0 0 0 0 0
Totale 6.230